US FDA Says Pfizer
Schizophrenia Drug Ad Misleading
(August 13, 2007) --
WASHINGTON, (Reuters) - A Pfizer Inc. advertisement for
schizophrenia drug
Geodon omitted important risk
information and contained unsupported claims that it was better than another
drug, U.S. regulators said in a letter released on Monday.
The Food and Drug Administration said the ad, which appeared in a medical
journal, was misleading. The agency sent a letter to Pfizer that was dated
July 16 and posted on the FDA Web site on Monday.
By Lisa Richwine
Source: Reuters
Last updated: 08/07
top ~
next ~
news table of contents ~
send page to a
friend
|